7-2-1 kapak görseli

7-2-1

7-2-1

Yazan: The Foundation For Women and Girls With Blood Disorders
Şimdi ücretsiz dinle, üyelik gerekmez

This Season's Biggest Deal | £0.99/mo for 3 months + £10 Audible bonus

£5.99/mo after 3 months - terms apply. Cancel monthly
Özet

7-2-1 is the podcast of the Foundation for Women & Girls with Blood Disorders (FWGBD).


Dr. Sweta Gupta has a passion for taking care of young women with bleeding disorders and heavy menstrual bleeding. 7-2-1 tackles some of the most pressing questions about periods and heavy menstrual bleeding faced by both healthcare providers and their patients: What is normal vs. heavy menstrual bleeding? Demystifying IUDS (LARCS). When should I see a specialist about my periods?


Join Dr. Gupta as she engages with the right expert(s) to help answer these questions. Each episode features conversations with leading medical experts, patients, and others who are involved in the field of blood disorders affecting women and girls. “The goal of this podcast is to provide engaging and useful content to healthcare providers, their patients, and others interested in learning more about this topic. The format of a podcast allows us to go more in-depth on these topics that are so critically important to healthcare professionals and our patients,” says Dr. Sweta Gupta, Pediatric Hematologist.



© 2026 7-2-1
Hygiene & Healthy Living Physical Illness & Disease
  • Anticoagulation and Heavy Menstrual Bleeding
    22 Jul 2026

    In this episode of 7-2-1: All You Need to Know About Periods, Dr. Bethany Samuelson Bannow leads an insightful discussion with experts, Luuk Scheres, MD, PhD and Eva Hamulyak, MD, PhD on Anticoagulation and Heavy Menstrual Bleeding.

    The conversation emphasizes the importance of understanding how anticoagulant therapy can exacerbate menstrual bleeding, especially in patients with a history of HMB or gynecological conditions. The experts discuss risk factors, the significance of patient education, and the need for healthcare providers to proactively engage in discussions about menstrual changes and potential anemia. Together, faculty highlight the lack of comprehensive research and the need for high-quality evidence to guide treatment strategies.

    This episode underscores the importance of interdisciplinary collaboration between hematologists and gynecologists to manage HMB effectively and calls for increased awareness and education among healthcare professionals and patients.

    Daha fazlasını göster Daha Az Göster
    38 dk.
  • H&T in Women with HHT: What the Clinician Needs to Know
    17 Apr 2026

    In this episode of 7-2-1: All You Need to Know About Periods, Dr. Bethany Samuelson Bannow leads an insightful discussion with experts, Dr. Hanny Al-Samkari and Dr. Layla Van Doren, on Hereditary Hemorrhagic Telangiectasia (HHT) and its complex relationship with thrombosis. Although HHT is widely recognized as a bleeding disorder, emerging evidence highlights an important and often underappreciated risk of clotting.

    This episode brings a focused lens to how HHT impacts menstruation and gynecologic health, particularly for women and girls across the lifespan. Heavy menstrual bleeding, iron deficiency, and challenges with hormonal management are explored alongside the competing risks of thrombosis. Together, faculty discuss how to approach menstrual management in HHT patients, including considerations when using estrogen-containing therapies, antifibrinolytics, and other treatment strategies.

    Daha fazlasını göster Daha Az Göster
    23 dk.
  • Repro Ready: The Essentials of Fertility Preservation
    12 Sep 2025

    In this episode of The 7-2-1, Dr. Kemi Olaiya and Dr. Cheryl Mensah continue the conversation on fertility preservation in sickle cell disease with Dr. Leslie Appiah, a leading expert in fertility preservation. Together, they break down what patients, families, and providers need to know, from insurance coverage and the hematologist’s role, to special considerations like hydration, anesthesia risks, and ovarian hyperstimulation syndrome. The discussion also explores how common sickle cell treatments such as hydroxyurea and iron chelation impact fertility preservation decisions. This episode offers practical insights for clinicians and families navigating complex choices around preserving fertility in the context of curative therapies.

    Daha fazlasını göster Daha Az Göster
    15 dk.
adbl_web_anon_alc_button_suppression_t1
Henüz yorum yok